Morphological evidence of ototoxicity of the iron chelator deferoxamine

被引:25
|
作者
Ryals, B
Westbrook, E
Schacht, J
机构
[1] MCGUIRE RES INST,RICHMOND,VA
[2] UNIV MICHIGAN,KRESGE HEARING RES INST,ANN ARBOR,MI 48109
关键词
ototoxicity; iron chelator; deferoxamine;
D O I
10.1016/S0378-5955(97)00094-4
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Recent reports of the role of iron-catalyzed free radical formation in gentamicin ototoxicity and the successful attenuation of gentamicin ototoxicity by iron chelators led us to re-examine experimental material from a previously unpublished study of deferoxamine. Deferoxamine was injected i.m. into adult Japanese quail at either 300 or 750 mg/kg body weight for 30 days. Examination of sections from the basilar papilla at the light microscope level indicated that supporting cells were damaged after the lower drug dose, and that both supporting cells and hair cells were damaged after the higher drug dose. High, prolonged exposure to deferoxamine produced pathological changes similar to those seen in the basilar papilla after much lower, shorter doses of gentamicin. These results demonstrate that deferoxamine damages the quail inner ear and are consistent with the idea that the ototoxic actions of gentamicin may be mediated by iron chelation.
引用
收藏
页码:44 / 48
页数:5
相关论文
共 50 条
  • [1] REDUCTION OF REPERFUSION INJURY WITH THE IRON CHELATOR DEFEROXAMINE
    AMBROSIO, G
    ZWEIER, JL
    JACOBUS, WE
    WEISFELDT, ML
    FLAHERTY, JT
    CIRCULATION, 1986, 74 (04) : 372 - 372
  • [2] PROTECTION FROM COLD INJURY BY DEFEROXAMINE, AN IRON CHELATOR
    MAITY, S
    LU, D
    RUSSEL, JC
    LYENGAR, J
    DAS, DK
    VASCULAR SURGERY, 1994, 28 (06): : 407 - 415
  • [3] PROTECTION FROM COLD INJURY BY DEFEROXAMINE, AN IRON CHELATOR
    MAITY, S
    LU, D
    RUSSEL, JC
    LYENGAR, J
    DAS, DK
    ANGIOLOGY, 1992, 43 (09) : 781 - 790
  • [4] PROTECTIVE EFFECT OF THE IRON CHELATOR DEFEROXAMINE ON CEREBRAL VASOSPASM
    CANER, H
    SENAATI, S
    BOLAY, H
    KILINC, K
    BENLI, K
    VASCULAR SURGERY, 1992, 26 (08): : 665 - 671
  • [5] The iron chelator deferoxamine decreases myeloma cell survival
    Yang, Feifei
    Wu, Zhaoxian
    Dai, Dan
    Zhang, Lei
    Zhang, Xiuqun
    Zhang, Xuezhong
    Xu, Yanli
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (01)
  • [6] Iron chelator deferoxamine induces epithelial transformation of tumor cells
    Rubtsova S.N.
    Vasil'ev Yu.M.
    Doklady Biological Sciences, 2006, 411 (1) : 517 - 519
  • [7] Effects of the iron chelator deferoxamine and of iron oxide nanoparticles on the proliferation of oligodendroglial cells
    Hohnholt, M.
    Geppert, M.
    Dringen, R.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 74 - 74
  • [8] THE OTOTOXICITY OF DEFEROXAMINE MESYLATE
    KANNO, H
    YAMANOBE, S
    RYBAK, LP
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1995, 16 (03) : 148 - 152
  • [9] Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine
    Breidbach, T
    Scory, S
    Krauth-Siegel, RL
    Steverding, D
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (04) : 473 - 479
  • [10] Deferoxamine, an iron chelator, promotes revascularization via endothelial cells activation
    Ikeda, Yasumasa
    Tajima, Soichiro
    Yoshida, Sumiko
    Yamano, Noriko
    Kihira, Yoshitaka
    Ishizawa, Keisuke
    Aihara, Ken-ichi
    Tomita, Shuhei
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 106P - 106P